HomeCancerProstate

Prostate

Grant to fund analysis on biomarkers for toxicity from prostate most cancers radiation

The Nationwide Most cancers Institute has awarded a $1.8 million grant to investigators on the College of California, Los Angeles (UCLA) Well being...

Tarlatamab Monotherapy Is Protected, Lively in DLL3+ Neuroendocrine Prostate Most cancers

Tarlatamab-dlle (Imdelltra) demonstrated a manageable security profile and early antitumor exercise in sufferers with DLL3-expressing neuroendocrine prostate most cancers (NEPC), in line with...

GE HealthCare’s (GEHC) New Answer to Support Prostate Therapy

GE HealthCare Applied sciences’ Inc. GEHC MIM Software program not too long ago launched the MIM Symphony HDR Prostate to assist excessive dose-rate (HDR)...

Hot Topics